Revvity Inc.
USUSDRevvity Inc. (XETRA:PKN) — Biotechnology: Laboratory Analytical Instruments. Numero di borse in cui sono quotate le azioni della società: 3. In questa pagina: prezzo e grafico, dividendi, principali azionisti e cronologia del numero di azioni.
Informazioni sull'Azienda
- Sito Web
- revvity.com
- Relazioni con gli Investitori
- ir.revvity.com/home/default.aspx
- Settore
- Industrials · Biotechnology: Laboratory Analytical Instruments
- Sede Centrale
- Waltham, United States
- Amministratore Delegato
- Prahlad R. Singh
- Dipendenti
- 11 000
- Azioni in Circolazione
- 111.59 Mln al 2026-08-06
- Flottante
- 102.49 Mln
- Capitalizzazione di Mercato
- 16.63 Mld USD
- Insider
- 0.26%
- Investitori Istituzionali
- 96.55%
- Settore (SIC)
- Laboratory Analytical Instruments
- Forma Giuridica
- ZJTK
- LEI
- 549300IKL1SDPFI7N655
- P/E
- 70.1
- Payout Ratio
- 13.4%
- FCF
- 558 Mln USD
- Pagamenti / FCF
- 6%
- Debito
- 3.21 Mld USD3.9 anni di FCF
- Serie di Dividendi
- 43 a.
- Utili, FCF e dividendi pagati — per i 12 mesi fino a 05.07.2026 (l'ultimo rapporto dell'azienda).
- NAV
Descrizione
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Dividendi
Revvity Inc. (RVTY) paga dividendi trimestralmente. All'anno (12 mesi fino all'ultimo pagamento annunciato): 0.28 USD per azione (pagamenti: 4). Questo rappresenta circa il 0.18% del prezzo attuale delle azioni. La prossima data ex-dividendo è il 23.10.2026: 0.07 USD per azione, pagamento il 13.11.2026. Storia dei dividendi ininterrotta: 43 anni.
| Data Ex | Pagamento | Importo | % | Tipo | Ticker |
|---|---|---|---|---|---|
| 2026-10-23 annunciato | 2026-11-13 | 0.0700 USD | 0.0/0.2 % | trimestrale | US:RVTY |
| 2026-07-17 | 2026-08-07 | 0.0700 USD | 0.1/0.3 % | trimestrale | US:RVTY |
| 2026-04-17 | 2026-05-08 | 0.0700 USD | 0.1/0.3 % | trimestrale | US:RVTY |
| 2026-01-16 | 2026-02-06 | 0.0700 USD | 0.1/0.2 % | trimestrale | US:RVTY |
| 2025-10-17 | 2025-11-07 | 0.0700 USD | 0.1/0.3 % | trimestrale | US:RVTY |
| 2025-07-18 | 2025-08-08 | 0.0700 USD | 0.1/0.3 % | trimestrale | US:RVTY |
| 2025-04-17 | 2025-05-09 | 0.0700 USD | 0.1/0.3 % | trimestrale | US:RVTY |
| 2025-01-17 | 2025-02-07 | 0.0700 USD | 0.1/0.2 % | trimestrale | US:RVTY |
| 2024-10-18 | 2024-11-08 | 0.0700 USD | 0.1/0.2 % | trimestrale | US:RVTY |
| 2024-07-19 | 2024-08-09 | 0.0700 USD | 0.0/0.2 % | trimestrale | US:RVTY |
| 2024-04-18 | 2024-05-10 | 0.0700 USD | 0.0/≈0.2 % | trimestrale | US:RVTY |
| 2024-01-18 | 2024-02-09 | 0.0700 USD | 0.0/≈0.2 % | trimestrale | US:RVTY |
| 2023-10-19 | 2023-11-10 | 0.0700 USD | 0.0/≈0.2 % | trimestrale | US:RVTY |
Notizie di Questa Settimana
Comunicati stampa dal sito web per investitori della società, aggiornati quotidianamente. I link conducono al sito web dell'azienda. I titoli sono nella lingua originale, come sul sito web dell'azienda.
Principali Azionisti
| Detentore | Quota | Azioni | Data del Rapporto |
|---|---|---|---|
| T. Rowe Price Investment… | 16.37% | 18.26 Mln | 2026-06-30 |
| T. ROWE PRICE CAPITAL AP… | 10.2% | 11.38 Mln | 2026-06-30 |
| Jupiter Topco LLC | 7.74% | 8.64 Mln | 2026-06-30 |
| Edgepoint Investment Gro… | 7.66% | 8.54 Mln | 2026-06-30 |
| Blackrock Inc. | 6.86% | 7.66 Mln | 2026-06-30 |
| Vanguard Capital Managem… | 6.54% | 7.3 Mln | 2026-06-30 |
| JANUS INVESTMENT FUND-Ja… | 5.15% | 5.75 Mln | 2026-06-30 |
| Price (T.Rowe) Associate… | 4.96% | 5.53 Mln | 2026-06-30 |
| Vanguard Portfolio Manag… | 4.28% | 4.77 Mln | 2026-06-30 |
| State Street Corporation | 3.89% | 4.34 Mln | 2026-06-30 |
| Victory Capital Manageme… | 3.27% | 3.65 Mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.18% | 3.55 Mln | 2026-06-30 |
| Dimensional Fund Advisor… | 3.07% | 3.43 Mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.59% | 2.89 Mln | 2026-06-30 |
| -Price (T.Rowe) U.S. Val… | 2.41% | 2.69 Mln | 2026-06-30 |
| TR PRICE-Price (T.Rowe)… | 2.41% | 2.69 Mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.29% | 2.56 Mln | 2026-06-30 |
| JNL Series Trust-JNL/T.… | 2.27% | 2.53 Mln | 2026-06-30 |
| Victory Portfolios-Victo… | 2.12% | 2.37 Mln | 2026-06-30 |
| T. Rowe Price Value Fund… | 1.93% | 2.16 Mln | 2026-06-30 |
| Invesco Exchange-Traded… | 1.67% | 1.87 Mln | 2026-08-31 |
| SINGH PRAHLAD R (Chief E… | ≈0.09% | 105 676 | 2026-08-13 |
| GOLDBERG JOEL S (General… | ≈0.09% | 105 223 | 2026-08-14 |
| BARRETT PETER (Director) | ≈0.03% | 28 293 | 2026-05-07 |
| WITNEY FRANKLIN R. PH.D.… | ≈0.02% | 23 354 | 2026-05-07 |
| CHAPIN SAMUEL R. (Direct… | ≈0.02% | 22 676 | 2026-05-07 |
| VICTOR MIRIAME (Officer) | ≈0.02% | 18 122 | 2026-02-24 |
| WITZ PASCALE (Director) | ≈0.01% | 15 985 | 2026-05-07 |
| KRAKOWIAK MAXWELL (Chief… | ≈0.01% | 14 781 | 2026-09-21 |
| MICHAS ALEXANDROS P (Dir… | — | — | 2026-08-25 |
| MICHAS ALEXIS P (Directo… | — | — | 2025-08-27 |
